Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-84,560
Closed -$450K 4949
2022
Q3
$450K Sell
84,560
-169,954
-67% -$1.28M ﹤0.01% 4109
2022
Q2
$2.28M Buy
254,514
+4,804
+2% +$55.8K ﹤0.01% 2951
2022
Q1
$4.42M Buy
249,710
+180,945
+263% +$5.63M ﹤0.01% 2453
2021
Q4
$3.91M Buy
68,765
+67,918
+8,019% +$4.53M ﹤0.01% 2656
2021
Q3
$64K Buy
+847
New +$89.6K ﹤0.01% 4785

Other funds holding GOCO

David Shaw's GOCO Position: Q4 2022 in Review

David Shaw sold out of GoHealth (GOCO) in Q4 2022, closing a stake of 84,560 shares — an estimated $450K sold.

David Shaw first reported a position in GOCO in Q3 2021 and held it in 5 quarters. The position peaked at $4.42M in Q1 2022. 35 funds tracked by Wall St. Rank hold GOCO as of Q4 2022.

  • David Shaw reported no remaining GoHealth position as of Q4 2022 after selling out during the quarter.
  • David Shaw sold 84,560 GoHealth shares in Q4 2022, an estimated $450K.
  • David Shaw first reported a position in GoHealth in Q3 2021 and held it in 5 quarters.
  • David Shaw's GoHealth position peaked at $4.42M in Q1 2022.
  • 35 funds tracked by Wall St. Rank held GoHealth as of Q4 2022.

Based on D.E. Shaw & Co's 13F filing for Q4 2022, filed 14 Feb 2023.